Douglas L Jennings

Summary

Affiliation: Henry Ford Hospital
Country: USA

Publications

  1. doi request reprint Successful treatment of a continuous flow left ventricular assist device thrombosis with eptifibatide
    Douglas L Jennings
    Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA
    ASAIO J 58:633-5. 2012
  2. doi request reprint Assessment of the heart failure pharmacotherapy of patients with continuous flow left-ventricular assist devices
    Douglas L Jennings
    Cardiovascular Intensive Care Unit, Department of Pharmacy Services, Henry Ford Hospital, Detroit, Michigan 48201, USA
    Int J Artif Organs 35:177-9. 2012
  3. doi request reprint Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure
    Douglas L Jennings
    Department of Pharmacy, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48201, USA
    Ann Pharmacother 43:1872-6. 2009
  4. doi request reprint Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis
    Douglas L Jennings
    Henry Ford Hospital, Department of Pharmacy Administration, 2799 West Grand Blvd, Detroit, MI 48201, USA
    J Clin Pharmacol 50:415-21. 2010
  5. doi request reprint The pharmacotherapy of the HeartMate II, a continuous flow left ventricular assist device, in patients with advanced heart failure: integration of disease, device, and drug
    Douglas L Jennings
    Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA
    Ann Pharmacother 44:1647-50. 2010
  6. doi request reprint The impact of pharmacist-directed patient education and anticoagulant care coordination on patient satisfaction
    Charles T Makowski
    College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 47:805-10. 2013
  7. doi request reprint Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices
    Douglas L Jennings
    From the Department of Pharmacy Practice, Nova Southeastern University, Ft Lauderdale, Florida Wayne State University, Detroit, Michigan Department of Pharmacy Services, Henry Ford Hospital, Detroit, Michigan Department of Cardiac Surgery, Henry Ford Hospital, Detroit, Michigan and Department of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan
    ASAIO J 60:381-4. 2014
  8. doi request reprint Assessing the potential of e-mail for communicating drug therapy recommendations to physicians in patients with heart failure and ventricular-assist devices
    Jona Lekura
    Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA
    J Pharm Pract 27:478-80. 2014
  9. doi request reprint Impact of Platelet Functional Assays on the Cost of Treating Suspected Heparin-Induced Thrombocytopenia
    Ziad G Sadik
    Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA
    J Pharm Pract 28:398-403. 2015
  10. doi request reprint Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support
    Douglas L Jennings
    Pharmacy Services, Henry Ford Hospital, Detroit, Michigan, USA
    ASAIO J 59:526-7. 2013

Collaborators

Detail Information

Publications16

  1. doi request reprint Successful treatment of a continuous flow left ventricular assist device thrombosis with eptifibatide
    Douglas L Jennings
    Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA
    ASAIO J 58:633-5. 2012
    ..The patient was transitioned to clopidogrel and discharged without further incident. Eptifibatide may represent a potential therapeutic option for patients with device thrombosis...
  2. doi request reprint Assessment of the heart failure pharmacotherapy of patients with continuous flow left-ventricular assist devices
    Douglas L Jennings
    Cardiovascular Intensive Care Unit, Department of Pharmacy Services, Henry Ford Hospital, Detroit, Michigan 48201, USA
    Int J Artif Organs 35:177-9. 2012
    ..The purpose of this project was to characterize the use of heart failure medications during the first year after left-ventricular assist device (LVAD) implantation...
  3. doi request reprint Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure
    Douglas L Jennings
    Department of Pharmacy, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48201, USA
    Ann Pharmacother 43:1872-6. 2009
    ..To review the literature evaluating the clinical effects of combination therapy with a beta-blocker and milrinone in patients with severe heart failure (HF)...
  4. doi request reprint Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis
    Douglas L Jennings
    Henry Ford Hospital, Department of Pharmacy Administration, 2799 West Grand Blvd, Detroit, MI 48201, USA
    J Clin Pharmacol 50:415-21. 2010
    ..21 and .48, respectively). The addition of cilostazol to standard dual antiplatelet therapy reduces angiographic restenosis and increases MLD at 6 months without significantly affecting rates of major adverse cardiac events or bleeding...
  5. doi request reprint The pharmacotherapy of the HeartMate II, a continuous flow left ventricular assist device, in patients with advanced heart failure: integration of disease, device, and drug
    Douglas L Jennings
    Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA
    Ann Pharmacother 44:1647-50. 2010
    ..The purpose of this article is to give clinical pharmacists an introduction to the most common pharmacotherapeutic issues for patients with LVADs and present practical solutions for managing common drug therapy problems...
  6. doi request reprint The impact of pharmacist-directed patient education and anticoagulant care coordination on patient satisfaction
    Charles T Makowski
    College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA
    Ann Pharmacother 47:805-10. 2013
    ..Clinical pharmacy services could improve satisfaction of hospital inpatients but it is unclear whether this relates to performance on standardized hospital surveys...
  7. doi request reprint Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices
    Douglas L Jennings
    From the Department of Pharmacy Practice, Nova Southeastern University, Ft Lauderdale, Florida Wayne State University, Detroit, Michigan Department of Pharmacy Services, Henry Ford Hospital, Detroit, Michigan Department of Cardiac Surgery, Henry Ford Hospital, Detroit, Michigan and Department of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan
    ASAIO J 60:381-4. 2014
    ..The mortality rate within 30 days of reversal was 20% (5/25), with three of these deaths associated with acute intracranial hemorrhage. Anticoagulation reversal may be safely attempted in selected patients under CF-LVAD support. ..
  8. doi request reprint Assessing the potential of e-mail for communicating drug therapy recommendations to physicians in patients with heart failure and ventricular-assist devices
    Jona Lekura
    Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA
    J Pharm Pract 27:478-80. 2014
    ..This project explores electronic mail (e-mail) as a potential medium for pharmacists to communicate pharmacotherapy interventions to prescribers...
  9. doi request reprint Impact of Platelet Functional Assays on the Cost of Treating Suspected Heparin-Induced Thrombocytopenia
    Ziad G Sadik
    Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA
    J Pharm Pract 28:398-403. 2015
    ..To investigate the potential cost savings of using functional platelet assays to confirm the diagnosis of heparin-induced thrombocytopenia (HIT)...
  10. doi request reprint Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support
    Douglas L Jennings
    Pharmacy Services, Henry Ford Hospital, Detroit, Michigan, USA
    ASAIO J 59:526-7. 2013
    ..1 mg/dl and 223 IU/L, respectively. The patient was successfully bridged to transplant in June 2012. Additional analysis of pentoxifylline as a therapeutic modality to manage hemolytic anemia after CF-LVAD implantation may be warranted...
  11. doi request reprint What should we be fine tuning in acute coronary syndromes--dosing of antiplatelet therapy or data presentation?
    Carrie W Nemerovski
    Wayne State University, Detroit, MI, USA
    Ann Pharmacother 45:120-2. 2011
    ..Using this trial as an example, this commentary emphasizes several key aspects of the clinical trial data presentation and publication process that need to improve and reminds clinicians of the many limitations to subgroup analyses...
  12. doi request reprint An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone
    Stephanie B Edwin
    Department of Pharmacy, University of Michigan, Ann Arbor, MI, USA
    J Clin Pharmacol 50:693-8. 2010
    ..Although these data should be viewed as hypothesis generating, cautious dosing and monitoring with simultaneous initiation of warfarin and amiodarone may be warranted...
  13. doi request reprint Device-Related Thrombosis in Continuous-Flow Left Ventricular Assist Device Support
    Christina Teeter Doligalski
    Department of Pharmacy, Tampa General Hospital, Tampa, FL, USA
    J Pharm Pract 29:58-66. 2016
    ..This review seeks to summarize the current literature surrounding the pathophysiology, diagnosis, and management of thrombosis in CF-LVAD recipients. ..
  14. doi request reprint Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients
    Douglas L Jennings
    Department of Pharmacy, New York Presbyterian Hospital, Columbia University Medical Center, 622 West 168th Street VC B, New York, NY, 10032, USA
    Heart Fail Rev 20:573-8. 2015
    ..As most of the studies included in this review suffered from small sample sizes and limited follow-up, additional research in this area is warranted. ..
  15. ncbi request reprint Predictors of rehospitalization after acute coronary syndromes
    Douglas L Jennings
    Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University WSU, Detroit, MI 48201, USA
    Am J Health Syst Pharm 63:367-72. 2006
  16. doi request reprint Extended use of a percutaneous left-ventricular assist device without a heparin-based purge solution
    Douglas L Jennings
    Cardiovascular Intensive Care Unit, Department of Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA
    Am J Health Syst Pharm 67:1825-8. 2010
    ..The extended use of an Impella LP 2.5 percutaneous left-ventricular assist device (pVAD) without a heparin-based purge solution in a patient who developed cardiogenic shock after acute myocardial infarction (AMI) is described...